221 related articles for article (PubMed ID: 24262869)
21. Neuroanatomical substrate of visuospatial and visuoperceptual impairment in Parkinson's disease.
Pereira JB; Junqué C; Martí MJ; Ramirez-Ruiz B; Bargalló N; Tolosa E
Mov Disord; 2009 Jun; 24(8):1193-9. PubMed ID: 19412935
[TBL] [Abstract][Full Text] [Related]
22. Olfaction and apathy in Parkinson's disease.
Cramer CK; Friedman JH; Amick MM
Parkinsonism Relat Disord; 2010 Feb; 16(2):124-6. PubMed ID: 19783195
[TBL] [Abstract][Full Text] [Related]
23. Morphometric changes of gray matter in Parkinson's disease with depression: a voxel-based morphometry study.
Feldmann A; Illes Z; Kosztolanyi P; Illes E; Mike A; Kover F; Balas I; Kovacs N; Nagy F
Mov Disord; 2008 Jan; 23(1):42-6. PubMed ID: 17973326
[TBL] [Abstract][Full Text] [Related]
24. Brain volume changes in Parkinson's disease and their relationship with cognitive and behavioural abnormalities.
Biundo R; Formento-Dojot P; Facchini S; Vallelunga A; Ghezzo L; Foscolo L; Meneghello F; Antonini A
J Neurol Sci; 2011 Nov; 310(1-2):64-9. PubMed ID: 21862438
[TBL] [Abstract][Full Text] [Related]
25. Neuroanatomical changes in early Parkinson's disease with mild cognitive impairment: a VBM study; the Parkinson's Disease Cognitive Impairment Study (PaCoS).
Donzuso G; Monastero R; Cicero CE; Luca A; Mostile G; Giuliano L; Baschi R; Caccamo M; Gagliardo C; Palmucci S; Zappia M; Nicoletti A
Neurol Sci; 2021 Sep; 42(9):3723-3731. PubMed ID: 33447925
[TBL] [Abstract][Full Text] [Related]
26. Neuroanatomical correlates of apathy in Parkinson's disease: A magnetic resonance imaging study using voxel-based morphometry.
Reijnders JS; Scholtissen B; Weber WE; Aalten P; Verhey FR; Leentjens AF
Mov Disord; 2010 Oct; 25(14):2318-25. PubMed ID: 20669264
[TBL] [Abstract][Full Text] [Related]
27. Analysis of olfactory function and the depth of olfactory sulcus in patients with Parkinson's disease.
Kim JY; Lee WY; Chung EJ; Dhong HJ
Mov Disord; 2007 Aug; 22(11):1563-6. PubMed ID: 17534948
[TBL] [Abstract][Full Text] [Related]
28. Thalamic volume and related visual recognition are associated with freezing of gait in non-demented patients with Parkinson's disease.
Sunwoo MK; Cho KH; Hong JY; Lee JE; Sohn YH; Lee PH
Parkinsonism Relat Disord; 2013 Dec; 19(12):1106-9. PubMed ID: 23938134
[TBL] [Abstract][Full Text] [Related]
29. Cognitive correlates of visual hallucinations in non-demented Parkinson's disease patients.
Hepp DH; da Hora CC; Koene T; Uitdehaag BM; van den Heuvel OA; Klein M; van de Berg WD; Berendse HW; Foncke EM
Parkinsonism Relat Disord; 2013 Sep; 19(9):795-9. PubMed ID: 23706540
[TBL] [Abstract][Full Text] [Related]
30. Voxel-based morphometry reveals extra-nigral atrophy patterns associated with dopamine refractory cognitive and motor impairment in parkinsonism.
Camicioli R; Gee M; Bouchard TP; Fisher NJ; Hanstock CC; Emery DJ; Martin WR
Parkinsonism Relat Disord; 2009 Mar; 15(3):187-95. PubMed ID: 18573676
[TBL] [Abstract][Full Text] [Related]
31. Side of motor onset is associated with hemisphere-specific memory decline and lateralized gray matter loss in Parkinson's disease.
Lee EY; Sen S; Eslinger PJ; Wagner D; Kong L; Lewis MM; Du G; Huang X
Parkinsonism Relat Disord; 2015 May; 21(5):465-70. PubMed ID: 25749355
[TBL] [Abstract][Full Text] [Related]
32. Does a volume reduction of the parietal lobe contribute to freezing of gait in Parkinson's disease?
Rubino A; Assogna F; Piras F; Di Battista ME; Imperiale F; Chiapponi C; Spalletta G; Meco G
Parkinsonism Relat Disord; 2014 Oct; 20(10):1101-3. PubMed ID: 25112926
[TBL] [Abstract][Full Text] [Related]
33. Neural correlates of minor hallucinations in non-demented patients with Parkinson's disease.
Pagonabarraga J; Soriano-Mas C; Llebaria G; López-Solà M; Pujol J; Kulisevsky J
Parkinsonism Relat Disord; 2014 Mar; 20(3):290-6. PubMed ID: 24373690
[TBL] [Abstract][Full Text] [Related]
34. Depressive symptoms in Parkinson's disease are related to decreased hippocampus and amygdala volume.
van Mierlo TJ; Chung C; Foncke EM; Berendse HW; van den Heuvel OA
Mov Disord; 2015 Feb; 30(2):245-52. PubMed ID: 25600157
[TBL] [Abstract][Full Text] [Related]
35. Temporal lobe changes in early, untreated Parkinson's disease.
Martin WR; Wieler M; Gee M; Camicioli R
Mov Disord; 2009 Oct; 24(13):1949-54. PubMed ID: 19606493
[TBL] [Abstract][Full Text] [Related]
36. Olfactory deficits and cognitive dysfunction in Parkinson's disease.
Parrao T; Chana P; Venegas P; Behrens MI; Aylwin ML
Neurodegener Dis; 2012; 10(1-4):179-82. PubMed ID: 22343138
[TBL] [Abstract][Full Text] [Related]
37. MRI and cognitive impairment in Parkinson's disease.
Ibarretxe-Bilbao N; Tolosa E; Junque C; Marti MJ
Mov Disord; 2009; 24 Suppl 2():S748-53. PubMed ID: 19877242
[TBL] [Abstract][Full Text] [Related]
38. Markers of brain illness may be hidden in your olfactory ability: a Japanese perspective.
Masaoka Y; Pantelis C; Phillips A; Kawamura M; Mimura M; Minegishi G; Homma I
Neurosci Lett; 2013 Aug; 549():182-5. PubMed ID: 23769725
[TBL] [Abstract][Full Text] [Related]
39. Brain correlates of progressive olfactory loss in Parkinson's disease.
Campabadal A; Uribe C; Segura B; Baggio HC; Abos A; Garcia-Diaz AI; Marti MJ; Valldeoriola F; Compta Y; Bargallo N; Junque C
Parkinsonism Relat Disord; 2017 Aug; 41():44-50. PubMed ID: 28522171
[TBL] [Abstract][Full Text] [Related]
40. Neuropsychiatric symptoms in Parkinson's disease: fronto-striatal atrophy contributions.
O'Callaghan C; Shine JM; Lewis SJ; Hornberger M
Parkinsonism Relat Disord; 2014 Aug; 20(8):867-72. PubMed ID: 24866458
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
